Loyal, a biotech startup in the U.S., plans to launch a daily pill, LOY-002, aimed at extending healthy life for dogs by at least one year. This research may also provide insights into human longevity. Meanwhile, the Dog Aging Project, led by researchers at the University of Washington, is exploring the effects of rapamycin, a drug that has shown promise in increasing lifespan in mice. Experts believe these studies could benefit both canine and human health, although challenges remain in establishing effective human biomarkers for aging.

Source